Top Markets
#1 Akedo Akedo +61.77%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.05%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.60%
#6 τemplar τemplar +27.06%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.57%
#8 Bitway Bitway +17.22%
#9 Perle Perle +16.80%
#10 Cap Cap +16.64%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Visioneering Technologies, Inc. Visioneering Technologies, Inc.

Visioneering Technologies, Inc.

VTI
Classement en actions #38209
Visioneering Technologies, Inc. is a medical device company focused on the... Visioneering Technologies, Inc. is a medical device company focused on the development, production, marketing, and distribution of contact lenses. Its commercial activities extend across North America, Europe, and the Asia-Pacific regions. The company's primary offering is NaturalVue, a multifocal contact lens engineered to help adults experiencing presbyopia and children with myopia. Visioneering Technologies was established in 2008 and has its main office situated in Alpharetta, Georgia.
Prix de l'action
$0.04200239
Dernière synchronisation: 2025-02-17
Capitalisation boursière
$1.13M
Changement (1 jour)
0.21%
Changement (1 an)
0.00%
Pays
US
Échange Visioneering Technologies, Inc. (VTI)

Catégorie

Healthcare
Bénéfices pour Visioneering Technologies, Inc. (VTI)
Bénéfices en Dec 2023 TTM : $-5.19M
Selon les derniers rapports financiers de Visioneering Technologies, Inc., les bénéfices actuels de l'entreprise sont de $-5.19M. En 2022, l'entreprise a réalisé un bénéfice de $-5.85M, une diminution par rapport à celui de 2021 qui était de $-1.69M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Visioneering Technologies, Inc. de 2016 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-5.19M 50.47%
2023 $-3.45M -41.06%
2022 $-5.85M 246.42%
2021 $-1.69M -76.17%
2020 $-7.08M -20.12%
2019 $-8.87M -31.48%
2018 $-12.94M -1.06%
2017 $-13.08M 62.56%
2016 $-8.05M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -144,908.00%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -99,350.65%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -107,351.62%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -74,537.98%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -27,430.56%
US